Trial Profile
Phase 2 study of melphalan hydrochloride in patients with intrahepatic cholangiocarcinoma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 21 Nov 2017
Price :
$35
*
At a glance
- Drugs Melphalan (Primary)
- Indications Cholangiocarcinoma
- Focus Registrational; Therapeutic Use
- Sponsors Delcath Systems
- 14 Nov 2017 According to a Delcath Systems media release, this trial is expected to begin in the in the fall of 2017.
- 21 Jan 2016 New trial record